MACY LOUTHAIN: Open Payments
NPI 1295419281 · BROWNSBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 57 payments from 10 companies in 2025. Trend: 2023 $68 · 2024 $785 · 2025 $1,068
Food & beverage: $1,068
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $264 |
| ABBVIE INC. | 16 | $233 |
| Collegium Pharmaceutical, Inc. | 8 | $175 |
| Astellas Pharma US Inc | 6 | $105 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| Amneal Pharmaceuticals LLC | 4 | $77 |
| SHIELD THERAPEUTICS INC | 2 | $40 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $31 |
| PFIZER INC. | 1 | $15 |
Products named: Ozempic, Jornay PM, VRAYLAR, Veozah, REXULTI, UBRELVY, UNITHROID, Wegovy.
Industry payments across IN — which companies pay providers there.
